Monday July 16, 2018
Home India Pollution Fig...

Pollution Fight: Iranian Technology for Two Wheelers might improve Delhi Air

Member of Parliament Meenakshi Lekhi says, the "pilot project is a sign of growing India-Iran cooperation, as the Iranian kits have been used for retro-fitment"

1
//
364
Air Pollution in Delhi. Image source: indianexpress.com
Republish
Reprint
  • The government plans to roll out new CNG two wheeler vehicles in collaboration with Iranian government
  • CNG emissions have 20% less CO gas and 75% less hydrocarbons
  • These vehicles will be closely monitored and based on the study, they will be rolled out in the whole country

Minister of State for Petroleum and Natural Gas (I/C) Shri Dharmendra Pradhan and Minister of State (I/C) for Environment, Forests & Climate Change Shri Prakash Javadekar jointly launched a pilot program for the first time in India to run two wheeler vehicles on CNG gas, with the help of Iran’s technology, in a new move to improve relations between the two countries.

Follow NewsGram on Twitter: @newsgram1

two wheeler
CNG gas station in Delhi. Image courtesy: Newsgram.com

The project, called ‘Hawa Badlo’ will comprise of 50 CNG powered vehicles, having a 4.8 liters of water capacity, plying across the city of Delhi. These vehicles will be closely monitored by the government and all the stakeholders based on their activities, running emissions and fuel usage per kilometer. The government plans on expanding this program throughout the country after a careful study of these parameters, said Sputnik.com report.

‘Hawa Badlo’, literally translates to ‘Change the air’, and in this case, it would refer to purifying the air of Indian cities. As per idle emission test, the hydrocarbon emissions from CNG retrofitted two wheelers are 75% lesser and CO emissions are 20% lesser as compared to petrol driven similar models.

M/s Ituk Manufacturing India Pvt. Ltd is an Indian company handling the task of fitting CNG kits with scooters. Around 0.4 million two wheeler vehicles will receive these kits. The company will be working in close cooperation with an Iranian company.  Approvals from Automotive Research Association of India (ARAI) as well as Transport Department, Govt. of NCT of Delhi have been obtained.

Follow NewsGram on Facebook: NewsGram

Sputnik News reports, according to the Center for Science & Environment, pollution from two wheeler vehicles account to one third of vehicular pollution. In a paper submitted by pib.nic.in, it is mentioned that these CNG fitted motorcycles and scooters will also be economically friendly. They can drive upto 120 kms in a single fill and are expected to be substantially economical as compared to a similar petrol run vehicle at the current level of prices, as per the kit manufacturer.

The government has been striving strongly to improve the air quality in New Delhi, and the rest of the country. Realizing the eminent danger of increasing pollution, The ‘Hawa Badlo’ movement is a people’s initiative to fight air pollution which is supported by GAIL and city gas distribution companies.

-This report is compiled by a Staff-writer at NewsGram. 

ALSO READ:

Click here for reuse options!
Copyright 2016 NewsGram

  • Vrushali Mahajan

    CNG two wheelers have great mileage too!

Next Story

Cepheid to Establish Manufacturing Unit for TB Diagnostics in India

Rifampicin is a drug commonly used in treating TB bacteria in first line of treatment

0
The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach.
The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach. (IANS)

Expanding its footprint in India, US-based molecular diagnostics company Cepheid Inc on Thursday announced its plans to establish a manufacturing unit in the country to improve Tuberculosis (TB) diagnostics.

Cepheid’s GeneXpert MTB/RIF test is a closed-cartridge-based system that is easy to operate by minimally trained staff and gives results in approximately two hours, speeding the conventional backlog that used to exist in traditional diagnostic methods.

The new manufacturing unit would produce MTB/RIF test cartridges, contribute to the government’s “Make in India” initiative and thus bringing the company’s global expertise in TB diagnostics to India, the company said in a statement.

As part of the plan, Cepheid also unveiled its latest portable, easy-to-use TB-testing system — the GeneXpert Edge — which is expected to be available in India later this year, the company said.

The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach.

“Cepheid recognises the need for technological advancement and is committed to contributing significantly to India’s goal of TB eradication,” said Peter Farrell, Executive Vice President, Worldwide Commercial Operations, Cepheid.

Cepheid's Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB)
Cepheid’s Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB).

“We are hopeful that GeneXpert Edge will help eliminate delays in TB diagnostics by providing definitive results within hours and facilitating fast and easy last-mile delivery even in the remote villages of India,” he added.

India has nearly one-fourth of the global TB patients and an estimated 4.8 lakh lives are lost every year due to delayed diagnosis and inadequate treatment and there are above 2.5 million new cases of TB every year. The country aims to eradicate TB by 2025.

Approved by the World Health Organisation (WHO) in 2010, more than 1,200 Cepheid’s GeneXpert Systems have been installed in the last two years at various Revised National Tuberculosis Control Programme (RNTCP) sites in the country and more than 2.5 million cartridges were supplied last year at various centres of Central TB Division (CTD).

Also Read: Fruit Bats Identified As Source Of Nipah Virus Outbreak in Kerala

Cepheid’s Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB) and rifampicin-resistance mutations, which are markers for MDR-TB strains in under two hours.

Rifampicin is a drug commonly used in treating TB bacteria in first line of treatment.

Xpert MTB/RIF tests also have excellent negative predictive value, which allows clinicians to manage TB-negative patients more effectively to prevent unnecessary and costly respiratory isolations. (IANS)